US20060091056A1 - Blood Treatment Filter Design to Trap Entrained Gas in a Blood Circuit - Google Patents

Blood Treatment Filter Design to Trap Entrained Gas in a Blood Circuit Download PDF

Info

Publication number
US20060091056A1
US20060091056A1 US11/163,702 US16370205A US2006091056A1 US 20060091056 A1 US20060091056 A1 US 20060091056A1 US 16370205 A US16370205 A US 16370205A US 2006091056 A1 US2006091056 A1 US 2006091056A1
Authority
US
United States
Prior art keywords
blood
purifier
header
holder
respect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/163,702
Inventor
James Brugger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NxStage Medical Inc
Original Assignee
NxStage Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NxStage Medical Inc filed Critical NxStage Medical Inc
Priority to US11/163,702 priority Critical patent/US20060091056A1/en
Assigned to NXSTAGE MEDICAL INC. reassignment NXSTAGE MEDICAL INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BRUGGER, JAMES M.
Publication of US20060091056A1 publication Critical patent/US20060091056A1/en
Assigned to GE BUSINESS FINANCIAL SERVICES INC. reassignment GE BUSINESS FINANCIAL SERVICES INC. SECURITY AGREEMENT Assignors: EIR MEDICAL, INC., MEDISYSTEMS CORPORATION, MEDISYSTEMS SERVICES CORPORATION, NXSTAGE MEDICAL, INC.
Assigned to MEDISYSTEMS SERVICES CORPORATION, EIR MEDICAL, INC., MEDISYSTEMS CORPORATION, NXSTAGE MEDICAL, INC. reassignment MEDISYSTEMS SERVICES CORPORATION RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: GE BUSINESS FINANCIAL SERVICES INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3627Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D19/00Degasification of liquids
    • B01D19/0021Degasification of liquids by bringing the liquid in a thin layer
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D19/00Degasification of liquids
    • B01D19/0042Degasification of liquids modifying the liquid flow
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/20Accessories; Auxiliary operations
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/24Dialysis ; Membrane extraction
    • B01D61/30Accessories; Auxiliary operation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/02Hollow fibre modules
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D65/00Accessories or auxiliary operations, in general, for separation processes or apparatus using semi-permeable membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/15Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with a cassette forming partially or totally the flow circuit for the treating fluid, e.g. the dialysate fluid circuit or the treating gas circuit
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/06External membrane module supporting or fixing means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/18Specific valves

Definitions

  • Treatment systems normally have air detectors to prevent air from being injected into a patient, either because a venous line carrying blood back to the patient contains air or because an infusate line, such as the replacement fluid line of a hemofiltration system, contains air. It is desirable for the air detectors to be made sufficiently sensitive to prevent the rare instances of long trains of air bubbles being injected into a patient. But sensitivity high enough to prevent long thin trains of bubbles may be high enough to alarm very small amounts of air which pose no risk. In other words, sensitive air detectors alarm on a lot of fall positives if they protect against all possible risks.
  • Air-settling chambers necessarily involve stagnant flow, which creates a risk of forming clots (e.g., for blood) or sedimentation or other concentration of entrained material (e.g. medication).
  • FIG. 1 is a cross-section view of a filter usable in a variety of different types of blood treatment systems oriented to trap air in one or two header portions of the filter.
  • FIGS. 2A through 2C illustrate holders for use with the filter device embodiment described herein, including a particular example of application to a blood treatment device such as that of FIG. 1 .
  • FIG. 2D illustrates an example of a holder feature to restrict orientations of a filter ensure that the filter is oriented with respect to the force of gravity.
  • FIG. 3 illustrates a filter similar to that of FIG. 1 but with a header port for removing air and/or disrupting or cleaning clots.
  • FIG. 4A illustrates an assembly for use with the port of FIG. 3 for removing air and/or disrupting or cleaning clots.
  • FIG. 4B illustrates a drip-chamber (or bubble trap) embodiment similar to the embodiment of FIG. 4A .
  • FIG. 5 illustrates a header cap with a hydrophobic membrane for automatically venting air.
  • FIGS. 6A through 9B illustrate a method for manufacturing a filter having a two-piece header caps that allow the use of a cylinder for a majority of the filter.
  • FIGS. 10A, 10B , and 11 illustrate the filter whose manufacture is described with respect to FIGS. 6A through 9B .
  • FIG. 12 shows an alternative configuration for connecting a dialysate manifold with a tubular body of the a filter according to an embodiment of the invention.
  • FIG. 13 illustrates a single element header component that uses a simple tube for the dialysate portion.
  • FIG. 1 is a cross-section view of a filter usable in a variety of different types of blood treatment systems oriented to trap air in one or two header portions of the filter.
  • a filter 100 which may be a dialyzer, hemofilter, hemodiafilter, or any other compatible blood treatment has a bundle of tubular media 132 connecting an arterial 160 and venous 155 head space which is isolated from a filtrate space 130 .
  • Blood flows through ports 122 and 124 in header caps 110 and 136 as indicated by arrows 118 and 112 into and out of the arterial 160 and venous 155 head spaces, respectively.
  • a cylindrical filter body 128 encloses the filtrate space 130 and contains filtrate (e.g., dialyzer) ports 126 and 120 .
  • Arterial and venous headers 142 and 134 isolate the filtrate space 130 from the respective arterial 160 and venous 155 head spaces.
  • the orientation of the filter 100 with respect to the pull of gravity is shown with the understanding that gravity is assumed to pull down with respect to the profile orientation of the drawing page. If any air is entrained in the blood, it may settle in pockets 151 and 153 in the arterial 160 and venous 155 head spaces as indicated by air/liquid interfaces 152 and 150 . The flow of blood through the arterial 160 and venous 155 head spaces is extremely slow due to the very small cross-sectional areas of the filter fibers in the bundle 132 . As a result, the arterial 160 and venous 155 head spaces are an idea place for air to settle out. With the indicated orientation, with blood outlet 124 pointing down and away from the pocket 151 . Since the blood moves at a very slow rate in the arterial 160 and venous 155 head spaces, there is little risk of reentrainment and air settles out very effectively.
  • Air trapped in pocket 153 may travel through filter fibers in bundle 132 up to venous head space 155 and accumulate in pocket 151 . Since the pocket 153 is located near the top of the arterial head space 160 , air will tend to travel up a few of the fibers closest to the top and collect in the pocket 151 without mixing in with blood. This keeps the vast majority of fibers filled with blood.
  • FIGS. 2A through 2C illustrate holder variations for the filter embodiments of the present patent disclosure.
  • the variations are intended to illustrate examples and not intended to be comprehensive or limiting.
  • a holder 175 of a blood treatment machine orients a filter such as that of FIG. 1 and those of the further filter embodiments described below.
  • the holder 175 may be attached at a base thereof (not shown separately) to a blood treatment machine 172 which may contain actuators, sensors, and control elements as well as a fluid circuit, here illustrated as a cartridge 180 enclosed between two parts 171 and 172 of the blood treatment machine 172 .
  • a filter 100 that is preconnected to the fluid circuit can easily be mounted in such an apparatus.
  • the holder 175 may be articulating to allow for some movement or change of orientation of the filter 100 and is preferably a spring-tensioned clamp that allows for one-handed insertion of a filter 100 .
  • the holder 175 may be attached to the 180 cartridge such that its orientation is obtained when the cartridge 180 is positioned with respect to the blood treatment machine 170 .
  • a holder 194 is integrated into a disposable unit 190 (such as the fluid circuit cartridge of FIG. 2A ).
  • the holder 194 may be made of wire which is connected to a plastic panel support 191 of the disposable unit. Examples of such disposable units are disclosed in U.S. Pat. No. 6,955,655 for “Hemofiltration system” and U.S. Pat.
  • the holder 194 supports a filter 192 such that when the disposable unit 190 is mounted, in a treatment device such as 170 , the filter 192 is held at an angle as shown.
  • FIG. 2C Another alternative arrangement shown in FIG. 2C is to provide a separate support 178 that is attached, or attachable, to a support 176 .
  • FIG. 2D illustrates an example of a holder feature to restrict orientations of a filter ensure that the filter is oriented with respect to the force of gravity.
  • the view is a sectional view.
  • the filter 166 has tabs 162 and 164 that prevent the filter 166 from being received fully within a flexible trough 168 which functions as a holder. This may be confirmed by inspection.
  • the flexible trough 168 allows the filter 166 body to fit into it fully in only one orientation, the holder providing an urging force that keeps the filter 166 in place when inserted.
  • FIG. 2D is only one of many devices that may be used to restrict the orientation of the filter when attached to a holder and is not intended to be limiting of the scope of any of the inventions described in the present disclosure.
  • FIG. 3 illustrates a filter similar to that of FIG. 1 but with a header cap 210 having an integrated header port 200 for removing air and/or disrupting or cleaning clots.
  • Tubing 265 may be connected to the port and provided with a clamp 260 .
  • the clamp 260 may be released, at intervals, by an operator, to vent air from the air pocket 251 and re-engaged to prevent blood loss.
  • the clamp 260 may be a normally-closed type clamp with a strong spring so that it reclamps tubing 265 when released.
  • the tubing 265 may be capped with a microporous filter end cap 253 to prevent any contamination re-entering the blood in the venous head space 155 .
  • the entire assembly that includes the filter 100 , tubing 265 , and microporous filter end cap 253 may be fused, sealed, and sterilized as a unit.
  • the same may be fused, sealed and sterilized as a unit with an entire treatment circuit, combining it with the circuit described in U.S. patent application Ser. No. 10/650,935 published as US 2004-0069709, which is hereby incorporated by reference as if full set forth in its entirety herein. With this combination, the entire circuit may be isolated from contamination.
  • FIG. 4A illustrates an assembly 350 for use with the port of FIG. 3 for removing air and/or disrupting or cleaning clots.
  • the port 200 has a tube 310 connecting the venous head space 155 with a multi-way valve (e.g., a stopcock as shown) 312 .
  • the multi-way valve 312 is further connected to a syringe 320 and tubing 375 connecting a supply of blood normal saline 375 , heparin, drug, or other medicament (such as from a tube 360 and bag 365 ) such as anticoagulants, drugs, etc.
  • the multi-way valve allows the syringe to be connected, in a first position, to draw saline from the source of saline 375 and, in a second position, to draw air from the venous head space 155 .
  • saline may be pushed into the head space 155 to clear clots or for prophylaxis by injecting medicament, for example, an anticoagulant such as heparin.
  • the multi-way valve 312 is set in the second position and air is drawn from the head space 155 . Then it is set in the first position and saline is drawn into the syringe 320 .
  • the multi-way valve 312 is set in the second position again and saline (or saline and heparin) is injected into the venous head space 155 .
  • the apparatus including the multi-way valve 312 , syringe 320 , tubing 310 , 375 , 360 and clamp 260 may be pre-attached to the filter 100 and presterilized as a unit.
  • a drip chamber 393 (which could also be a bubble trap or other similar device in which air may accumulate and possibly be vented), has an inlet 391 and an outlet 394 .
  • a connection 392 to the top of the drip chamber 393 may be connected to the line 310 shown in FIG. 4A and used in the manner described for removing air and/or injecting medicaments.
  • FIG. 5 illustrates a header cap 210 with cover 280 sealed to and covering the header port 200 .
  • the cover includes a hydrophobic membrane 285 that allows air in the head space 155 to vent automatically while preventing any contamination from entering.
  • a method for manufacturing a filter design begins with the insertion of a filter fiber bundle 420 into a cylindrical tube 405 which forms part of a housing (discussed with reference to FIG. 11 ).
  • the tube 405 is a straight tube with no other structural features, in the present example.
  • the tube 405 may be a thin walled structure allowing material to be saved.
  • it may be made of a material that is not necessarily injection moldable, as filter housings generally are.
  • a preferred material is glycol-modified polyethylene terephthalate, a copolyester (PETG) which may be a clear amorphous thermoplastic with high stiffness, hardness, and toughness as well as good impact strength.
  • PETG copolyester
  • Other advantages of using a tube for the main part of the housing will become clear from the further description below. Note that in the drawing only one end of the tube is shown in the present and following figures, but a complementary operation may be performed at an opposite end of the tube 405 such that a mirror-image structure is obtained.
  • the filter fiber membrane bundle 420 may be inserted such that the fibers 415 extend beyond the end 407 of the tube 405 as indicated at 445 .
  • the resulting combination 430 of tube 405 and filter fibers 420 may be inserted in a dialysis cap 435 .
  • dialysis cap is for convenience is not intended to limit the scope of the invention to the manufacture of a dialyzer.
  • the outer surface of the tube 405 lies adjacent an inner annular surface 440 of the dialysis cap and a 450 bond is formed by thermal welding or sealing using adhesive, solvent, or filling type bonding agent such as urethane to form a completed structure 480 .
  • a symmetrical structure is formed at the opposite end so that both ends of the tube 405 have a dialysate cap 435 .
  • potting caps are placed over the ends of the structure 480 and the ends of the fiber bundle are potted as according methods that are known in the art of manufacturing filters.
  • a preferred method of potting is described in U.S. Pat. No. 6,872,346 for a “Method and apparatus for manufacturing filters,” which is hereby incorporated by reference as if fully set forth in its entirety herein.
  • the result of potting is the creation of a sealed end of potting material indicated at 440 which, after hardening, is cut along a planar surface indicated at 460 .
  • the cut 460 is done in such a way that the end of the filter fibers 420 are open at the surface 465 forming.
  • a portion of the dialysate cap 435 may be trimmed off in the process of cutting 460 , as illustrated, although it will be apparent to those skilled in the art that this is not essential and instead, the fibers 420 could extend beyond the end of the dialysate cap 435 before potting such that the fibers 420 can be opened by cutting without cutting the dialysis cap 435 .
  • the completed end portion is shown in FIG. 8B , and as discussed, a symmetrical end portion may be completed at the opposite end (not shown here).
  • Respective blood caps 505 and 605 are fitted to the ends 600 A and 600 B of the structure 480 .
  • Each blood cap has a respective blood port 510 , 610 and one of the blood caps has a secondary port 610 which will be recognized from the discussion of embodiments such as shown and discussed with respect to FIGS. 3 through 5 .
  • the blood caps 505 and 605 have respective header spaces 645 that are preferably hydraulically shaped to ensure that no, or a minimal number of, dead (stagnant flow of blood) spaces arise when in use.
  • a rim 515 fits into an annular recess 470 (or rim 615 into annular recess 471 ).
  • a bead 605 , 606 , 607 , 608 of adhesive or sealing material may be applied or injected in the annular recesses 470 and 471 to form a bond between the structure 480 and the respective blood caps 505 and 605 .
  • the bonding may be done by thermal, friction, solvent welding, compression bonding, or other technique.
  • Dialysate ports 30 and 531 in the dialysate caps 435 and 425 allow dialysate to flow into and out of the space occupied by bundle 420 and in contact with the external surfaces of the filter bundle 420 .
  • a hemofilter or other kinds of filters such as sterile filters, reverse osmosis filters, ultrafilters, etc.; only one “dialysate” port would be required.
  • Blood ports 510 and 610 in blood caps 505 and 605 respectively, supply blood into, and be recovered from, the header spaces 545 and 645 , respectively. Air can be removed from air removal/access port 610 . As explained above, removal/access port 610 can also be used for injection of anticoagulants, drugs, or other medicaments.
  • a small gap 685 , 686 is provided between the end 407 ( FIGS. 6A, 7A , 8 A) of the tube 405 ( FIGS. 6A, 6B ) and the surface of the potting 440 to allow dialysate to flow into the space occupied by the filter bundle 420 .
  • the dialysate (or filtrate, depending on the application) is distributed by an annular dialysate manifold space 626 , 626 .
  • FIG. 11 shows a complete filter unit.
  • One of the benefits of the design is that it makes it possible to confine the capital expense associated with injection molding to the dialysate and blood header reducing first costs in new filter designs.
  • the design allows the tubular portion to be lengthened and shorted without requiring major design and manufacturing changes.
  • injection molding is not contemplated to be a requirement for the practice of the invention or all its embodiments, it is a preferred means for achieving the high precision and economies of scale for articles of manufacture such as dialyzers, filters, and hemofilters, as well as other applications of the disclosed embodiments.
  • a tube for the filtrate/dialysate portion of the filter can be obtained by using a single-element header cap rather than separate “dialysate” and “blood” caps.
  • a one-piece cap 725 has an annular dialysate manifold 740 that is sealed by O-rings 747 against the surface of a tube 760 .
  • a blood header space 732 is in communication with a blood port 730 and the dialysate manifold 740 is in communication with a dialysate port 735 .
  • Slits 750 (configured such as illustrated in FIG. 11 ) allow fluid communication between the dialysate manifold 740 and the external surfaces of the fiber bundle 733 .
  • a potting plug 745 in addition to performing its normal function, serves to reinforce the cylindrical structure of the tube 760 against the pressure of the O-ring 747 seals.
  • a tube is permitted to be used with a single-element cap 725 structure providing many of the benefits of the inventions discussed above.
  • a tension band 757 may be used to ensure a good seal and provide a final shape to the one-piece cap 725 if made of a somewhat compliant resin to allow it to be removed from an injection mold despite the recess defined by the dialysate manifold 740 .
  • the one-piece cap 725 may have a discontinuous dialysate manifold that allows it to be created without requiring the cap to yield, the cap could be machined rather than molded, or the cap could be made of two molded pieces that are assembled into a single cap. Many variations are possible.

Abstract

A configuration of a blood microtubular filter/dializer used in many kinds of renal replacement therapy systems can provide highly a effective mechanism for removing air from the blood circuit of such systems. In embodiments, for example, the invention takes advantage of the slow flow rate that usually occurs where blood exits the microtubules into a header area of the filter to provide a settling area.

Description

    BACKGROUND
  • One of the problems with fluid circuits in blood treatment systems is entrained air (bubbles) in treatment fluids, infusate, or blood. Treatment systems normally have air detectors to prevent air from being injected into a patient, either because a venous line carrying blood back to the patient contains air or because an infusate line, such as the replacement fluid line of a hemofiltration system, contains air. It is desirable for the air detectors to be made sufficiently sensitive to prevent the rare instances of long trains of air bubbles being injected into a patient. But sensitivity high enough to prevent long thin trains of bubbles may be high enough to alarm very small amounts of air which pose no risk. In other words, sensitive air detectors alarm on a lot of fall positives if they protect against all possible risks.
  • A prior art approach has been to remove as much air from a protected fluid circuit as possible. Putting air traps in fluid circuits, particularly blood lines, has drawbacks. Air-settling chambers necessarily involve stagnant flow, which creates a risk of forming clots (e.g., for blood) or sedimentation or other concentration of entrained material (e.g. medication).
  • The inventive embodiments provide various other features and advantages in addition to or in lieu of those discussed above and below. Many of these features and advantages are apparent from the description below with reference to the following drawing.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a cross-section view of a filter usable in a variety of different types of blood treatment systems oriented to trap air in one or two header portions of the filter.
  • FIGS. 2A through 2C illustrate holders for use with the filter device embodiment described herein, including a particular example of application to a blood treatment device such as that of FIG. 1.
  • FIG. 2D illustrates an example of a holder feature to restrict orientations of a filter ensure that the filter is oriented with respect to the force of gravity.
  • FIG. 3 illustrates a filter similar to that of FIG. 1 but with a header port for removing air and/or disrupting or cleaning clots.
  • FIG. 4A illustrates an assembly for use with the port of FIG. 3 for removing air and/or disrupting or cleaning clots.
  • FIG. 4B illustrates a drip-chamber (or bubble trap) embodiment similar to the embodiment of FIG. 4A.
  • FIG. 5 illustrates a header cap with a hydrophobic membrane for automatically venting air.
  • FIGS. 6A through 9B illustrate a method for manufacturing a filter having a two-piece header caps that allow the use of a cylinder for a majority of the filter.
  • FIGS. 10A, 10B, and 11 illustrate the filter whose manufacture is described with respect to FIGS. 6A through 9B.
  • FIG. 12 shows an alternative configuration for connecting a dialysate manifold with a tubular body of the a filter according to an embodiment of the invention.
  • FIG. 13 illustrates a single element header component that uses a simple tube for the dialysate portion.
  • DETAILED DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a cross-section view of a filter usable in a variety of different types of blood treatment systems oriented to trap air in one or two header portions of the filter. A filter 100, which may be a dialyzer, hemofilter, hemodiafilter, or any other compatible blood treatment has a bundle of tubular media 132 connecting an arterial 160 and venous 155 head space which is isolated from a filtrate space 130. Blood flows through ports 122 and 124 in header caps 110 and 136 as indicated by arrows 118 and 112 into and out of the arterial 160 and venous 155 head spaces, respectively. A cylindrical filter body 128 encloses the filtrate space 130 and contains filtrate (e.g., dialyzer) ports 126 and 120. Arterial and venous headers 142 and 134 isolate the filtrate space 130 from the respective arterial 160 and venous 155 head spaces.
  • The orientation of the filter 100 with respect to the pull of gravity is shown with the understanding that gravity is assumed to pull down with respect to the profile orientation of the drawing page. If any air is entrained in the blood, it may settle in pockets 151 and 153 in the arterial 160 and venous 155 head spaces as indicated by air/ liquid interfaces 152 and 150. The flow of blood through the arterial 160 and venous 155 head spaces is extremely slow due to the very small cross-sectional areas of the filter fibers in the bundle 132. As a result, the arterial 160 and venous 155 head spaces are an idea place for air to settle out. With the indicated orientation, with blood outlet 124 pointing down and away from the pocket 151. Since the blood moves at a very slow rate in the arterial 160 and venous 155 head spaces, there is little risk of reentrainment and air settles out very effectively.
  • Air trapped in pocket 153 may travel through filter fibers in bundle 132 up to venous head space 155 and accumulate in pocket 151. Since the pocket 153 is located near the top of the arterial head space 160, air will tend to travel up a few of the fibers closest to the top and collect in the pocket 151 without mixing in with blood. This keeps the vast majority of fibers filled with blood.
  • FIGS. 2A through 2C illustrate holder variations for the filter embodiments of the present patent disclosure. The variations are intended to illustrate examples and not intended to be comprehensive or limiting. In FIG. 2A, a holder 175 of a blood treatment machine orients a filter such as that of FIG. 1 and those of the further filter embodiments described below. The holder 175 may be attached at a base thereof (not shown separately) to a blood treatment machine 172 which may contain actuators, sensors, and control elements as well as a fluid circuit, here illustrated as a cartridge 180 enclosed between two parts 171 and 172 of the blood treatment machine 172. A filter 100 that is preconnected to the fluid circuit can easily be mounted in such an apparatus. The holder 175 may be articulating to allow for some movement or change of orientation of the filter 100 and is preferably a spring-tensioned clamp that allows for one-handed insertion of a filter 100. In an alternative embodiment, the holder 175 may be attached to the 180 cartridge such that its orientation is obtained when the cartridge 180 is positioned with respect to the blood treatment machine 170. In FIG. 2B, a holder 194 is integrated into a disposable unit 190 (such as the fluid circuit cartridge of FIG. 2A). For example, the holder 194 may be made of wire which is connected to a plastic panel support 191 of the disposable unit. Examples of such disposable units are disclosed in U.S. Pat. No. 6,955,655 for “Hemofiltration system” and U.S. Pat. No. 6,579,253 for “Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge,” each of which is hereby incorporated by reference as if full set forth in its entirety herein and U.S. patent application Ser. No. 10/650,935 published as US 2004-0069709, which is incorporated by reference above. The holder 194 supports a filter 192 such that when the disposable unit 190 is mounted, in a treatment device such as 170, the filter 192 is held at an angle as shown. Another alternative arrangement shown in FIG. 2C is to provide a separate support 178 that is attached, or attachable, to a support 176.
  • FIG. 2D illustrates an example of a holder feature to restrict orientations of a filter ensure that the filter is oriented with respect to the force of gravity. The view is a sectional view. In the example, the filter 166 has tabs 162 and 164 that prevent the filter 166 from being received fully within a flexible trough 168 which functions as a holder. This may be confirmed by inspection. The flexible trough 168 allows the filter 166 body to fit into it fully in only one orientation, the holder providing an urging force that keeps the filter 166 in place when inserted. Note that the example illustrated in FIG. 2D is only one of many devices that may be used to restrict the orientation of the filter when attached to a holder and is not intended to be limiting of the scope of any of the inventions described in the present disclosure.
  • FIG. 3 illustrates a filter similar to that of FIG. 1 but with a header cap 210 having an integrated header port 200 for removing air and/or disrupting or cleaning clots. Tubing 265 may be connected to the port and provided with a clamp 260. The clamp 260 may be released, at intervals, by an operator, to vent air from the air pocket 251 and re-engaged to prevent blood loss. The clamp 260 may be a normally-closed type clamp with a strong spring so that it reclamps tubing 265 when released. The tubing 265 may be capped with a microporous filter end cap 253 to prevent any contamination re-entering the blood in the venous head space 155. The entire assembly that includes the filter 100, tubing 265, and microporous filter end cap 253 may be fused, sealed, and sterilized as a unit. In addition the same may be fused, sealed and sterilized as a unit with an entire treatment circuit, combining it with the circuit described in U.S. patent application Ser. No. 10/650,935 published as US 2004-0069709, which is hereby incorporated by reference as if full set forth in its entirety herein. With this combination, the entire circuit may be isolated from contamination.
  • FIG. 4A illustrates an assembly 350 for use with the port of FIG. 3 for removing air and/or disrupting or cleaning clots. The port 200 has a tube 310 connecting the venous head space 155 with a multi-way valve (e.g., a stopcock as shown) 312. The multi-way valve 312 is further connected to a syringe 320 and tubing 375 connecting a supply of blood normal saline 375, heparin, drug, or other medicament (such as from a tube 360 and bag 365) such as anticoagulants, drugs, etc. The multi-way valve allows the syringe to be connected, in a first position, to draw saline from the source of saline 375 and, in a second position, to draw air from the venous head space 155. In the second position, saline may be pushed into the head space 155 to clear clots or for prophylaxis by injecting medicament, for example, an anticoagulant such as heparin. In an illustrative usage method, the multi-way valve 312 is set in the second position and air is drawn from the head space 155. Then it is set in the first position and saline is drawn into the syringe 320. Then the multi-way valve 312 is set in the second position again and saline (or saline and heparin) is injected into the venous head space 155. The apparatus including the multi-way valve 312, syringe 320, tubing 310, 375, 360 and clamp 260 may be pre-attached to the filter 100 and presterilized as a unit.
  • Note that besides using the multi-way valve and bag 365 to draw air from the header of a filter and inject medicaments into the filter header, the same devices may be used in connection with an air trap or drip chamber. Referring to FIG. 4B, a drip chamber 393 (which could also be a bubble trap or other similar device in which air may accumulate and possibly be vented), has an inlet 391 and an outlet 394. A connection 392 to the top of the drip chamber 393 may be connected to the line 310 shown in FIG. 4A and used in the manner described for removing air and/or injecting medicaments.
  • FIG. 5 illustrates a header cap 210 with cover 280 sealed to and covering the header port 200. The cover includes a hydrophobic membrane 285 that allows air in the head space 155 to vent automatically while preventing any contamination from entering.
  • Referring to FIGS. 6A and 6B, a method for manufacturing a filter design that incorporates features of the foregoing examples begins with the insertion of a filter fiber bundle 420 into a cylindrical tube 405 which forms part of a housing (discussed with reference to FIG. 11). The tube 405 is a straight tube with no other structural features, in the present example. As such, the tube 405 may be a thin walled structure allowing material to be saved. In addition, it may be made of a material that is not necessarily injection moldable, as filter housings generally are. A preferred material is glycol-modified polyethylene terephthalate, a copolyester (PETG) which may be a clear amorphous thermoplastic with high stiffness, hardness, and toughness as well as good impact strength. Other advantages of using a tube for the main part of the housing will become clear from the further description below. Note that in the drawing only one end of the tube is shown in the present and following figures, but a complementary operation may be performed at an opposite end of the tube 405 such that a mirror-image structure is obtained.
  • The filter fiber membrane bundle 420 may be inserted such that the fibers 415 extend beyond the end 407 of the tube 405 as indicated at 445. Referring now to FIGS. 7A and 7B, the resulting combination 430 of tube 405 and filter fibers 420 may be inserted in a dialysis cap 435. Note that the term “dialysis cap” is for convenience is not intended to limit the scope of the invention to the manufacture of a dialyzer. The outer surface of the tube 405 lies adjacent an inner annular surface 440 of the dialysis cap and a 450 bond is formed by thermal welding or sealing using adhesive, solvent, or filling type bonding agent such as urethane to form a completed structure 480. A symmetrical structure is formed at the opposite end so that both ends of the tube 405 have a dialysate cap 435.
  • Referring now to FIGS. 8A and 8B, potting caps (not shown) are placed over the ends of the structure 480 and the ends of the fiber bundle are potted as according methods that are known in the art of manufacturing filters. A preferred method of potting is described in U.S. Pat. No. 6,872,346 for a “Method and apparatus for manufacturing filters,” which is hereby incorporated by reference as if fully set forth in its entirety herein. The result of potting is the creation of a sealed end of potting material indicated at 440 which, after hardening, is cut along a planar surface indicated at 460. The cut 460 is done in such a way that the end of the filter fibers 420 are open at the surface 465 forming. A portion of the dialysate cap 435 may be trimmed off in the process of cutting 460, as illustrated, although it will be apparent to those skilled in the art that this is not essential and instead, the fibers 420 could extend beyond the end of the dialysate cap 435 before potting such that the fibers 420 can be opened by cutting without cutting the dialysis cap 435. The completed end portion is shown in FIG. 8B, and as discussed, a symmetrical end portion may be completed at the opposite end (not shown here).
  • Referring now to FIGS. 9A through 11, the two ends 600A and 600B of a single tube structure are indicated. Respective blood caps 505 and 605 are fitted to the ends 600A and 600B of the structure 480. Each blood cap has a respective blood port 510, 610 and one of the blood caps has a secondary port 610 which will be recognized from the discussion of embodiments such as shown and discussed with respect to FIGS. 3 through 5. The blood caps 505 and 605 have respective header spaces 645 that are preferably hydraulically shaped to ensure that no, or a minimal number of, dead (stagnant flow of blood) spaces arise when in use. In the embodiment shown, a rim 515 fits into an annular recess 470 (or rim 615 into annular recess 471). Prior to fitting the blood caps 505 and 605, a bead 605, 606, 607, 608 of adhesive or sealing material may be applied or injected in the annular recesses 470 and 471 to form a bond between the structure 480 and the respective blood caps 505 and 605. The bonding may be done by thermal, friction, solvent welding, compression bonding, or other technique. Dialysate ports 30 and 531 in the dialysate caps 435 and 425, respectively, allow dialysate to flow into and out of the space occupied by bundle 420 and in contact with the external surfaces of the filter bundle 420. For a hemofilter or other kinds of filters, such as sterile filters, reverse osmosis filters, ultrafilters, etc.; only one “dialysate” port would be required. Blood ports 510 and 610 in blood caps 505 and 605, respectively, supply blood into, and be recovered from, the header spaces 545 and 645, respectively. Air can be removed from air removal/access port 610. As explained above, removal/access port 610 can also be used for injection of anticoagulants, drugs, or other medicaments.
  • As best seen in FIGS. 10A and 10B, a small gap 685, 686 is provided between the end 407 (FIGS. 6A, 7A, 8A) of the tube 405 (FIGS. 6A, 6B) and the surface of the potting 440 to allow dialysate to flow into the space occupied by the filter bundle 420. The dialysate (or filtrate, depending on the application) is distributed by an annular dialysate manifold space 626, 626. Referring momentarily to FIG. 12, it is noted that instead of providing for the gap 685, 686 in the manner described, the fiber bundle may be extended all the way to the end 407 of the tube 405 and openings 705 can be provided to perform the function of the openings 685, 686. The same features provide for extraction of filtrate or dialysate or other fluid depending on the application. FIG. 11 shows a complete filter unit. One of the benefits of the design is that it makes it possible to confine the capital expense associated with injection molding to the dialysate and blood header reducing first costs in new filter designs. In addition, the design allows the tubular portion to be lengthened and shorted without requiring major design and manufacturing changes. Note that although injection molding is not contemplated to be a requirement for the practice of the invention or all its embodiments, it is a preferred means for achieving the high precision and economies of scale for articles of manufacture such as dialyzers, filters, and hemofilters, as well as other applications of the disclosed embodiments.
  • Referring to FIG. 13, the benefit of using a tube for the filtrate/dialysate portion of the filter can be obtained by using a single-element header cap rather than separate “dialysate” and “blood” caps. In the example shown, a one-piece cap 725 has an annular dialysate manifold 740 that is sealed by O-rings 747 against the surface of a tube 760. A blood header space 732 is in communication with a blood port 730 and the dialysate manifold 740 is in communication with a dialysate port 735. Slits 750 (configured such as illustrated in FIG. 11) allow fluid communication between the dialysate manifold 740 and the external surfaces of the fiber bundle 733. A potting plug 745, in addition to performing its normal function, serves to reinforce the cylindrical structure of the tube 760 against the pressure of the O-ring 747 seals. In this embodiment, a tube is permitted to be used with a single-element cap 725 structure providing many of the benefits of the inventions discussed above.
  • A tension band 757 may be used to ensure a good seal and provide a final shape to the one-piece cap 725 if made of a somewhat compliant resin to allow it to be removed from an injection mold despite the recess defined by the dialysate manifold 740. Alternatively, the one-piece cap 725 may have a discontinuous dialysate manifold that allows it to be created without requiring the cap to yield, the cap could be machined rather than molded, or the cap could be made of two molded pieces that are assembled into a single cap. Many variations are possible.
  • It will be understood that while the invention has been described above in conjunction with a few exemplary embodiments, the description and examples are intended to illustrate and not limit the scope of the invention. That which is described herein with respect to the exemplary embodiments can be applied to the measurement of many different formation characteristics. Thus, the scope of the invention should only be limited by the following claims.

Claims (14)

1. A blood treatment apparatus, comprising:
a blood purifier including microtubular filter membranes in a bundle with one end of said bundle terminating in a first manifold at a lower end of said blood purifier and a second end of said bundle terminating in a second manifold, blood flowing in an upward direction through said filter media during use;
said purifier having first and second header chambers forming respective passages where flow divides and coalesces in said first and second manifolds, respectively;
said second header having an outlet where a coalesced flow from said second manifold flows out of said second header;
said purifier being of generally cylindrical construction with a longitudinal axis parallel to said microtubular membranes;
a holder configured to hold said purifier in a preferred orientation in which said longitudinal axis forms an angle with respect to a direction of gravitation force and with said outlet at a position remote from a highest point of said second header resulting from said orientation, whereby any gas bubbles in blood in said second header tend to rise and be trapped at said highest point and not flow out said outlet;
said holder and a body of said purifier having mechanical features that prevent engagement of said purifier in said holder unless said purifier is in said preferred orientation with respect to said holder, thereby ensuring said purifier is used in said preferred orientation;
said holder being fixedly mountable on a blood processing machine or some other base of reference in a fixed orientation.
2. An apparatus as in claim 1, wherein said holder is fixedly mounted on a blood processing machine.
3. A blood treatment apparatus, comprising:
a blood purifier including filter media into which blood comes in contact during use;
said purifier having a header chamber where multiple flows of blood combine at a position where blood exits a portion of said blood purifier, said header chamber having at least one outlet;
a holder configured to support said purifier in a position and orientation such that air can accumulate in said header chamber in a position remote from said outlet whereby said header chamber is enabled to remove air from blood.
4. Apparatus as in claim 3, wherein said blood purifier includes microtubular blood purifier fibers and is attached to a fluid circuit and forms a part of a disposable set.
5. Apparatus as in claim 3, wherein said holder and said purifier are configured to permit said purifier to be attached in only one orientation, whereby a preferred orientation of said purifier is ensured.
6. Apparatus as in claim 3, wherein said holder is fixedly attachable to a blood treatment machine.
7. Apparatus as in claim 3, wherein said blood purifier has a longitudinal axis and said holder is configured to support said blood purifier with said longitudinal axis at an angle with respect to the vertical, as defined with respect to the force of gravity.
8. A blood treatment apparatus, comprising:
a blood dialyzer or hemofilter processing element including filter media into which blood comes in contact during use;
said processing element having a chamber at an exit of a treatment portion thereof where blood flow velocity drops to a low rate, said chamber having at least one outlet;
a holder attachable to a blood treatment machine and configurable to support said processing element in a position and orientation such that air can accumulate in said header chamber in a position remote from said outlet whereby said header chamber is enabled to remove air from blood.
9. Apparatus as in claim 8, wherein said processing element is attached to a fluid circuit and forms a part of a disposable set.
10. Apparatus as in claim 8, wherein said processing element is attached to a fluid circuit and forms a part of a disposable set, said fluid circuit having a support with said holder thereattached such that when said fluid circuit is connected to said blood treatment machine, said processing element is so positioned oriented.
11. Apparatus as in claim 8, wherein said blood purifier has a longitudinal axis and said holder is configured to support said blood purifier with said longitudinal axis at an angle with respect to the vertical, as defined with respect to the force of gravity.
12. Apparatus as in claim 8, wherein said holder and said processing element are configured to permit said processing element to be attached in only one orientation, whereby a preferred orientation of said processing element is ensured.
13. A blood treatment apparatus, comprising
a blood treatment device that includes a tubular media fiber bundle;
a header having a header space connecting as a manifold outlets of said tubular media such that blood flowing therethrough coalesces into a single flow in said header that exits through an outlet of said header;
said header having a blood outlet;
a holder configured to support said blood treatment device in one position and orientation with respect thereto;
said holder being configurable to connect to a blood treatment machine such that said blood treatment device is oriented with respect to said blood treatment machine;
said header being shaped permit air to collect therein in a location above outlet, whereby gases coming out of solution in said tubular media collect in the slow moving header space and are not reentrained in an exiting blood flow.
14. Apparatus as in claim 13, wherein said blood treatment device has a longitudinal axis and said holder, when said fluid circuit is connected to said blood treatment machine is configured to support said blood treatment device with said longitudinal axis at an angle with respect to the vertical, as defined with respect to the force of gravity.
US11/163,702 2004-10-28 2005-10-27 Blood Treatment Filter Design to Trap Entrained Gas in a Blood Circuit Abandoned US20060091056A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/163,702 US20060091056A1 (en) 2004-10-28 2005-10-27 Blood Treatment Filter Design to Trap Entrained Gas in a Blood Circuit

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62286304P 2004-10-28 2004-10-28
US11/163,702 US20060091056A1 (en) 2004-10-28 2005-10-27 Blood Treatment Filter Design to Trap Entrained Gas in a Blood Circuit

Publications (1)

Publication Number Publication Date
US20060091056A1 true US20060091056A1 (en) 2006-05-04

Family

ID=36319501

Family Applications (6)

Application Number Title Priority Date Filing Date
US11/577,126 Abandoned US20100096311A1 (en) 2004-10-28 2005-09-16 Blood treatment dialyzer/filter design to trap entrained air in a fluid circuit
US11/163,708 Abandoned US20060091058A1 (en) 2004-10-28 2005-10-27 Blood Treatment Dialyzer/Filter Design to Remove Entrained Gas and Add Medicaments
US11/163,703 Abandoned US20060091057A1 (en) 2004-10-28 2005-10-27 Blood Treatment Dialyzer/Filter Design to Trap and Remove Entrained Gas
US11/163,702 Abandoned US20060091056A1 (en) 2004-10-28 2005-10-27 Blood Treatment Filter Design to Trap Entrained Gas in a Blood Circuit
US12/432,507 Active 2026-03-01 US7901579B2 (en) 2004-10-28 2009-04-29 Blood treatment dialyzer/filter for permitting gas removal
US13/025,306 Abandoned US20110126714A1 (en) 2004-10-28 2011-02-11 Blood treatment dialyzer/filter for permitting gas removal

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US11/577,126 Abandoned US20100096311A1 (en) 2004-10-28 2005-09-16 Blood treatment dialyzer/filter design to trap entrained air in a fluid circuit
US11/163,708 Abandoned US20060091058A1 (en) 2004-10-28 2005-10-27 Blood Treatment Dialyzer/Filter Design to Remove Entrained Gas and Add Medicaments
US11/163,703 Abandoned US20060091057A1 (en) 2004-10-28 2005-10-27 Blood Treatment Dialyzer/Filter Design to Trap and Remove Entrained Gas

Family Applications After (2)

Application Number Title Priority Date Filing Date
US12/432,507 Active 2026-03-01 US7901579B2 (en) 2004-10-28 2009-04-29 Blood treatment dialyzer/filter for permitting gas removal
US13/025,306 Abandoned US20110126714A1 (en) 2004-10-28 2011-02-11 Blood treatment dialyzer/filter for permitting gas removal

Country Status (2)

Country Link
US (6) US20100096311A1 (en)
WO (1) WO2006049822A1 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070102340A1 (en) * 2005-10-27 2007-05-10 Nxstage Medical, Inc. Blood treatment filter and method of manufacturing
US20090229466A1 (en) * 2004-10-28 2009-09-17 Brugger James M Blood treatment dialyzer/filter for permitting gas removal
WO2014124180A2 (en) * 2013-02-06 2014-08-14 Nxstage Medical, Inc. Fluid circuit priming methods, devices, and systems
WO2014158999A1 (en) * 2013-03-14 2014-10-02 Leberthon Brian J Method and device for treating cancer
CN104986820A (en) * 2015-07-21 2015-10-21 江苏沁尔康环境电器有限公司 Exhausting method of reverse osmosis water purifier and reverse osmosis water purifier realizing exhausting method
US20150300524A1 (en) * 2012-12-03 2015-10-22 Fresenius Medical Care Deutschland Gmbh Device for quickly venting and draining a filter
US10258731B2 (en) * 2007-09-13 2019-04-16 Fresenius Medical Care Holdings, Inc. Manifold diaphragms
US10758868B2 (en) 2008-10-30 2020-09-01 Fresenius Medical Care Holdings, Inc. Methods and systems for leak detection in a dialysis system
US10758662B2 (en) 2007-11-29 2020-09-01 Fresenius Medical Care Holdings, Inc. Priming system and method for dialysis systems
US10758661B2 (en) 2007-11-29 2020-09-01 Fresenius Medical Care Holdings, Inc. Disposable apparatus and kit for conducting dialysis
US10808861B2 (en) 2009-01-12 2020-10-20 Fresenius Medical Care Holdings, Inc. Valve system
US10817004B2 (en) 2013-11-11 2020-10-27 Fresenius Medical Care Holdings, Inc. Valve system with a pressure sensing displacement member
US11071811B2 (en) 2007-09-13 2021-07-27 Fresenius Medical Care Holdings, Inc. Portable dialysis machine
CN113304341A (en) * 2016-03-31 2021-08-27 旭化成医疗株式会社 Blood purification system and priming method thereof
US11169137B2 (en) 2008-10-30 2021-11-09 Fresenius Medical Care Holdings, Inc. Modular reservoir assembly for a hemodialysis and hemofiltration system
US11187572B2 (en) 2012-12-24 2021-11-30 Fresenius Medical Care Holdings, Inc. Dialysis systems with a suspended reservoir
US11224841B2 (en) 2007-09-25 2022-01-18 Fresenius Medical Care Holdings, Inc. Integrated disposable component system for use in dialysis systems
US11318248B2 (en) 2007-09-13 2022-05-03 Fresenius Medical Care Holdings, Inc. Methods for heating a reservoir unit in a dialysis system
JP7085800B2 (en) 2016-03-31 2022-06-17 旭化成メディカル株式会社 Blood purifier, blood purification kit, and blood purification system
US11525798B2 (en) 2012-12-21 2022-12-13 Fresenius Medical Care Holdings, Inc. Method and system of monitoring electrolyte levels and composition using capacitance or induction

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1532994B1 (en) * 2003-11-24 2014-04-09 Gambro Lundia AB Degassing device and end-cap assembly for a filter
US8535522B2 (en) 2009-02-12 2013-09-17 Fresenius Medical Care Holdings, Inc. System and method for detection of disconnection in an extracorporeal blood circuit
US8040493B2 (en) 2007-10-11 2011-10-18 Fresenius Medical Care Holdings, Inc. Thermal flow meter
US20120234746A1 (en) * 2009-09-14 2012-09-20 John Howard Filter blood fluid channel methods, devices, and systems
US8753515B2 (en) 2009-12-05 2014-06-17 Home Dialysis Plus, Ltd. Dialysis system with ultrafiltration control
US8501009B2 (en) 2010-06-07 2013-08-06 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Fluid purification system
CN102172476B (en) * 2011-03-24 2012-12-19 中国人民解放军第三军医大学野战外科研究所 Dialysis membrane fixing device
WO2013052680A2 (en) 2011-10-07 2013-04-11 Home Dialysis Plus, Ltd. Heat exchange fluid purification for dialysis system
ES2864727T3 (en) 2014-04-29 2021-10-14 Outset Medical Inc Dialysis system and methods
EP3799943A3 (en) 2015-10-31 2021-07-14 Saint-Gobain Performance Plastics Corporation Truncated filter capsule
WO2017170971A1 (en) * 2016-03-31 2017-10-05 旭化成メディカル株式会社 Hollow fiber membrane module and method for manufacturing same
JP6953162B2 (en) * 2016-03-31 2021-10-27 旭化成メディカル株式会社 Blood purifier
EP3437723A4 (en) * 2016-03-31 2019-04-17 Asahi Kasei Medical Co., Ltd. Hollow fiber membrane module and method for manufacturing hollow fiber membrane module
ES2908601T3 (en) 2016-08-19 2022-05-03 Outset Medical Inc Peritoneal dialysis system and methods
CA3131931A1 (en) * 2019-02-28 2020-09-03 Qidni Labs Inc. Systems and methods of gas removal from a wearable device
US20200316279A1 (en) * 2019-04-02 2020-10-08 Fresenius Medical Care Holdings, Inc. Air management device for dialysis machines
WO2021094139A1 (en) 2019-11-12 2021-05-20 Fresenius Medical Care Deutschland Gmbh Blood treatment systems
CA3160967A1 (en) 2019-11-12 2021-05-20 Fresenius Medical Care Deutschland Gmbh Blood treatment systems
WO2021094140A1 (en) 2019-11-12 2021-05-20 Fresenius Medical Care Deutschland Gmbh Blood treatment systems
CA3160952A1 (en) 2019-11-12 2021-05-20 Fresenius Medical Care Deutschland Gmbh Blood treatment systems
CN113796900B (en) * 2020-06-17 2023-06-16 温州市人民医院 Laparoscope sleeve with air suction function

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863421A (en) * 1995-02-13 1999-01-26 Aksys, Ltd. Hemodialysis machine with automatic priming by induced pressure pulses
US5951870A (en) * 1997-10-21 1999-09-14 Dsu Medical Corporation Automatic priming of blood sets
US6579253B1 (en) * 1997-02-14 2003-06-17 Nxstage Medical, Inc. Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218313A (en) * 1977-05-23 1980-08-19 Extracorporeal Medical Specialties, Inc. Dialysis apparatus and technique
US4201673A (en) * 1977-07-04 1980-05-06 Terumo Corporation Apparatus for dialysis of solution
US4293413A (en) * 1979-12-28 1981-10-06 Baxter Travenol Laboratories, Inc. Dialyzer blood circuit and bubble traps
SE427619B (en) * 1981-10-05 1983-04-25 Gambro Lundia Ab A filtering
SE451056B (en) * 1982-09-10 1987-08-31 Gambro Lundia Ab SLANGSET PROVIDED FOR EXTRACORPORAL TREATMENT OF BLOOD AND SIMILAR EXCESSIVE LIQUID
US4620965A (en) * 1982-09-22 1986-11-04 Terumo Corporation Hollow fiber-type artificial lung
US4617161A (en) * 1983-09-06 1986-10-14 Baxter Travenol Laboratories, Inc. Method of manufacture for a dialyzer having improved side ports
US4651144A (en) * 1985-04-26 1987-03-17 Pagano Raymond V Security housing with motion detector
DE3709432A1 (en) * 1987-03-21 1988-10-06 Fresenius Ag CAPILLARY FILTER ARRANGEMENT FOR THE STERILIZATION OF LIQUID MEDIA
SE454847B (en) * 1987-08-31 1988-06-06 Gambro Dialysatoren DEVICE FOR DIFFUSION AND / OR FILTERING AND PROCEDURE FOR MANUFACTURING THIS DEVICE
US4976685A (en) * 1988-06-15 1990-12-11 Block Jr Frank E Method of blood-gas interface control in surgical gas traps
US5486286A (en) 1991-04-19 1996-01-23 Althin Medical, Inc. Apparatus for performing a self-test of kidney dialysis membrane
US5698090A (en) * 1991-09-10 1997-12-16 Hospal Industrie Artificial kidney for adjusting a concentration of substance in blood
US5910252A (en) * 1993-02-12 1999-06-08 Cobe Laboratories, Inc. Technique for extracorporeal treatment of blood
JPH0768136A (en) * 1993-09-02 1995-03-14 Tsuchiya Mfg Co Ltd Hollow-fiber membrane type separation module and manufacture thereof
DE59507027D1 (en) * 1994-07-13 1999-11-18 Fresenius Medical Care De Gmbh Substitute preparation for hemofiltration or hemodiafiltration
FR2723002B1 (en) * 1994-07-26 1996-09-06 Hospal Ind DEVICE AND METHOD FOR PREPARING A FILTRATION PROCESSING LIQUID
US5643190A (en) * 1995-01-17 1997-07-01 Medisystems Technology Corporation Flow-through treatment device
US5676644A (en) * 1995-06-07 1997-10-14 Cobe Laboratories, Inc. Extracorporeal blood processing methods and apparatus
US5641144A (en) * 1995-06-07 1997-06-24 Cobe Laboratories, Inc. Dialyzer holder
US5774027A (en) * 1995-08-25 1998-06-30 Sanyo Electric Co., Ltd. Band-pass filter with trap circuits having different Q factors
DE19534417A1 (en) * 1995-09-16 1997-03-20 Fresenius Ag Method for checking at least one filter arranged in the dialysis fluid system of a device for extracorporeal blood treatment
DE19546027C1 (en) * 1995-12-09 1997-04-03 Fresenius Ag Appts. removing toxic substances from blood by dialysis or related techniques
US20010016699A1 (en) 1997-02-14 2001-08-23 Jeffrey H. Burbank Hemofiltration system
US6979309B2 (en) * 1997-02-14 2005-12-27 Nxstage Medical Inc. Systems and methods for performing blood processing and/or fluid exchange procedures
DE19708391C1 (en) * 1997-03-01 1998-10-22 Fresenius Medical Care De Gmbh Method and device for ultrafiltration in hemodialysis
DE19719555A1 (en) * 1997-05-09 1998-11-12 Kevin Business Corp Method and device for separating gas from gaseous blood
US6071269A (en) * 1998-05-13 2000-06-06 Medisystems Technology Corporation Blood set and chamber
DE19857850C2 (en) * 1998-12-15 2003-02-06 Fresenius Medical Care De Gmbh filter means
US6315895B1 (en) * 1999-12-30 2001-11-13 Nephros, Inc. Dual-stage hemodiafiltration cartridge
AU2001290593A1 (en) * 2000-08-31 2002-03-13 Millipore Corporation Gas vent filter construction incorporating a hollow fiber membrane assembly
JP4053421B2 (en) 2000-12-11 2008-02-27 ネフロス・インコーポレーテッド Hemodiafiltration / blood filtration cartridge
US6649063B2 (en) * 2001-07-12 2003-11-18 Nxstage Medical, Inc. Method for performing renal replacement therapy including producing sterile replacement fluid in a renal replacement therapy unit
US20030010718A1 (en) * 2001-07-12 2003-01-16 Nxstage Medical, Inc. Hemodilution cap and methods of use in blood-processing procedures
SE523610C2 (en) * 2001-10-02 2004-05-04 Gambro Lundia Ab Method of controlling dialysis device
DE10159620C1 (en) * 2001-12-05 2003-08-14 Fresenius Medical Care De Gmbh Method and device for monitoring the supply of substitution fluid during extracorporeal blood treatment
ITMI20020359A1 (en) * 2002-02-22 2003-08-22 Gambro Lundia Ab METHOD OF CONTROL OF THE OPERATION OF A FLOW INTERDICTION BODY AND A FLOW STOP DEVICE FOR AN EXTRA-BODY CIRCUIT
US7297255B2 (en) * 2002-03-28 2007-11-20 Entegris, Inc. Mass or energy transfer cartridge and module
US7125396B2 (en) * 2002-12-30 2006-10-24 Cardinal Health 303, Inc. Safety catheter system and method
US6872346B2 (en) * 2003-03-20 2005-03-29 Nxstage Medical, Inc. Method and apparatus for manufacturing filters
KR101131343B1 (en) * 2004-05-07 2012-04-04 감브로 룬디아 아베 Blood treatment equipment, method and software program for controlling infusion
EP1784248B1 (en) * 2004-06-09 2014-07-30 Renal Solutions, Inc. Dialysis system
US20100096311A1 (en) * 2004-10-28 2010-04-22 Nxstage Medical, Inc Blood treatment dialyzer/filter design to trap entrained air in a fluid circuit
US20070102340A1 (en) * 2005-10-27 2007-05-10 Nxstage Medical, Inc. Blood treatment filter and method of manufacturing

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863421A (en) * 1995-02-13 1999-01-26 Aksys, Ltd. Hemodialysis machine with automatic priming by induced pressure pulses
US6579253B1 (en) * 1997-02-14 2003-06-17 Nxstage Medical, Inc. Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge
US5951870A (en) * 1997-10-21 1999-09-14 Dsu Medical Corporation Automatic priming of blood sets

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090229466A1 (en) * 2004-10-28 2009-09-17 Brugger James M Blood treatment dialyzer/filter for permitting gas removal
US20100096311A1 (en) * 2004-10-28 2010-04-22 Nxstage Medical, Inc Blood treatment dialyzer/filter design to trap entrained air in a fluid circuit
US7901579B2 (en) 2004-10-28 2011-03-08 Nxstage Medical, Inc. Blood treatment dialyzer/filter for permitting gas removal
US20110126714A1 (en) * 2004-10-28 2011-06-02 Nxstage Medical, Inc. Blood treatment dialyzer/filter for permitting gas removal
US20070102340A1 (en) * 2005-10-27 2007-05-10 Nxstage Medical, Inc. Blood treatment filter and method of manufacturing
US20090236027A1 (en) * 2005-10-27 2009-09-24 Nxstage Medical, Inc. Blood Treatment Filter and Method of Manufacturing
US11071811B2 (en) 2007-09-13 2021-07-27 Fresenius Medical Care Holdings, Inc. Portable dialysis machine
US11318248B2 (en) 2007-09-13 2022-05-03 Fresenius Medical Care Holdings, Inc. Methods for heating a reservoir unit in a dialysis system
US10258731B2 (en) * 2007-09-13 2019-04-16 Fresenius Medical Care Holdings, Inc. Manifold diaphragms
US10857281B2 (en) 2007-09-13 2020-12-08 Fresenius Medical Care Holdings, Inc. Disposable kits adapted for use in a dialysis machine
US11224841B2 (en) 2007-09-25 2022-01-18 Fresenius Medical Care Holdings, Inc. Integrated disposable component system for use in dialysis systems
US10758661B2 (en) 2007-11-29 2020-09-01 Fresenius Medical Care Holdings, Inc. Disposable apparatus and kit for conducting dialysis
US10758662B2 (en) 2007-11-29 2020-09-01 Fresenius Medical Care Holdings, Inc. Priming system and method for dialysis systems
US11439738B2 (en) 2007-11-29 2022-09-13 Fresenius Medical Care Holdings, Inc. Methods and Systems for fluid balancing in a dialysis system
US10758868B2 (en) 2008-10-30 2020-09-01 Fresenius Medical Care Holdings, Inc. Methods and systems for leak detection in a dialysis system
US11169137B2 (en) 2008-10-30 2021-11-09 Fresenius Medical Care Holdings, Inc. Modular reservoir assembly for a hemodialysis and hemofiltration system
US10808861B2 (en) 2009-01-12 2020-10-20 Fresenius Medical Care Holdings, Inc. Valve system
US20150300524A1 (en) * 2012-12-03 2015-10-22 Fresenius Medical Care Deutschland Gmbh Device for quickly venting and draining a filter
US10082222B2 (en) * 2012-12-03 2018-09-25 Fresenius Medical Care Deutschland Gmbh Device for quickly venting and draining a filter
US11525798B2 (en) 2012-12-21 2022-12-13 Fresenius Medical Care Holdings, Inc. Method and system of monitoring electrolyte levels and composition using capacitance or induction
US11187572B2 (en) 2012-12-24 2021-11-30 Fresenius Medical Care Holdings, Inc. Dialysis systems with a suspended reservoir
US11344658B2 (en) 2013-02-06 2022-05-31 Nxstage Medical, Inc. Fluid circuit priming methods, devices, and systems
US10022484B2 (en) * 2013-02-06 2018-07-17 Nxstage Medical, Inc. Fluid circuit priming methods, devices, and systems
WO2014124180A3 (en) * 2013-02-06 2014-10-02 Nxstage Medical, Inc. Fluid circuit priming methods, devices, and systems
US10835662B2 (en) * 2013-02-06 2020-11-17 Nxstage Medical, Inc. Fluid circuit priming methods, devices, and systems
WO2014124180A2 (en) * 2013-02-06 2014-08-14 Nxstage Medical, Inc. Fluid circuit priming methods, devices, and systems
US20180256807A1 (en) * 2013-02-06 2018-09-13 Nxstage Medical, Inc. Fluid Circuit Priming Methods, Devices, and Systems
US10869959B2 (en) 2013-03-14 2020-12-22 Brian J. LeBerthon Method and device for treating cancer
US9227005B2 (en) 2013-03-14 2016-01-05 Brian J LeBerthon Method and device for treating cancer
WO2014158999A1 (en) * 2013-03-14 2014-10-02 Leberthon Brian J Method and device for treating cancer
US10817004B2 (en) 2013-11-11 2020-10-27 Fresenius Medical Care Holdings, Inc. Valve system with a pressure sensing displacement member
CN104986820A (en) * 2015-07-21 2015-10-21 江苏沁尔康环境电器有限公司 Exhausting method of reverse osmosis water purifier and reverse osmosis water purifier realizing exhausting method
CN113304341A (en) * 2016-03-31 2021-08-27 旭化成医疗株式会社 Blood purification system and priming method thereof
JP7085800B2 (en) 2016-03-31 2022-06-17 旭化成メディカル株式会社 Blood purifier, blood purification kit, and blood purification system

Also Published As

Publication number Publication date
US20090229466A1 (en) 2009-09-17
US20100096311A1 (en) 2010-04-22
WO2006049822A1 (en) 2006-05-11
US7901579B2 (en) 2011-03-08
US20110126714A1 (en) 2011-06-02
US20060091058A1 (en) 2006-05-04
US20060091057A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
US7901579B2 (en) Blood treatment dialyzer/filter for permitting gas removal
EP2864025B1 (en) Capillary dialyzers
KR100649260B1 (en) Dual-stage filtration cartridge
EP1433490B1 (en) Dialyzer and method for manufacturing the same
EP1532994B1 (en) Degassing device and end-cap assembly for a filter
US6635179B1 (en) Sterile fluid filtration cartridge and method for using same
EP2796185A1 (en) Hollow fiber membrane module and casing tube used for same
US9254464B2 (en) Filter module
EP3782672B1 (en) Pressure detector
US20030057147A1 (en) Filtration device and system for biological fluids
EP1398047B1 (en) End-cap for a dialyser, dialyser and method for removing gas bubbles
US9999736B2 (en) Device and external functional means and treatment apparatus for the treatment of medical fluids
KR20170117564A (en) Hollow Sterilized Blood Purifier
US20090236027A1 (en) Blood Treatment Filter and Method of Manufacturing
JP6637960B2 (en) Filter module
EP2404664A1 (en) A support for a separation device and extracorporeal blood treatment using said support and separation device
JP2000042100A (en) Hollow fiber membrane type liquid treatment apparatus
JP4362399B2 (en) Hollow fiber blood purifier
CN215460731U (en) Improved blood ultrafilter and hemodialysis system
CN112041002B (en) Air trap chamber and extracorporeal circulation circuit
JP2016112089A (en) Blood purification system and blood purifier
CN113490518A (en) Dialyzer and dialysis apparatus
JP2006158456A (en) Blood purifying apparatus

Legal Events

Date Code Title Description
AS Assignment

Owner name: NXSTAGE MEDICAL INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BRUGGER, JAMES M.;REEL/FRAME:016944/0583

Effective date: 20051219

AS Assignment

Owner name: GE BUSINESS FINANCIAL SERVICES INC., CONNECTICUT

Free format text: SECURITY AGREEMENT;ASSIGNORS:NXSTAGE MEDICAL, INC.;EIR MEDICAL, INC.;MEDISYSTEMS CORPORATION;AND OTHERS;REEL/FRAME:022610/0602

Effective date: 20090316

Owner name: GE BUSINESS FINANCIAL SERVICES INC.,CONNECTICUT

Free format text: SECURITY AGREEMENT;ASSIGNORS:NXSTAGE MEDICAL, INC.;EIR MEDICAL, INC.;MEDISYSTEMS CORPORATION;AND OTHERS;REEL/FRAME:022610/0602

Effective date: 20090316

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: NXSTAGE MEDICAL, INC., MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

Owner name: EIR MEDICAL, INC., MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

Owner name: MEDISYSTEMS CORPORATION, MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

Owner name: MEDISYSTEMS SERVICES CORPORATION, MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

Owner name: NXSTAGE MEDICAL, INC.,MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

Owner name: EIR MEDICAL, INC.,MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

Owner name: MEDISYSTEMS CORPORATION,MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

Owner name: MEDISYSTEMS SERVICES CORPORATION,MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605